Tirzepatide is a prescription medication used for adults with obesity or those who are overweight. Recharge Lab offers Tirzepatide in a once-weekly injection formula. This medication can reduce your appetite by mimicking a hormone that targets the area of the brain responsible for regulating food intake. You might also recognize this medication by the brand Mounjaro. Patients are expected to combine their prescription treatment with an appropriate diet and exercise routine for maximum results.
Our Tirzepatide Medical Weight Loss Program in Orange County is carefully monitored by our physician. All patients are required to receive blood work prior to starting the program. Call us today to set up your obligation-free consultation!
You will meet with one of our expert medical providers to discuss your goals and current BMI. You will also discuss a medical history to make sure this medication is right for you.
We will put in your blood work order through Quest labs. Once the results come in and are cleared by our physician, your medication will be ordered. You will have a pickup appointment where our provider will discuss how to administer the medication.
See your weight loss dreams come to life!
You will also have a scheduled follow up appointment virtually with our physician to monitor your treatment.
© Recharge Labs, All Rights Reserved 2022
THE CONTENTS OF THE WEBSITE, SUCH AS TEXT, GRAPHICS, IMAGES, AND OTHER MATERIAL CONTAINED ON THE WEBSITE (“CONTENT”) ARE FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE MEDICAL ADVICE. THE CONTENT AND SERVICES LISTED HERE ARE OPINIONS ONLY AND HAVE NOT BEEN EVALUATED, RECOMMENDED, OR ENDORSED BY THE FDA OR ANY OTHER GOVERNMENT ORGANIZATION. THE CONTENT IS NOT INTENDED TO BE A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT. ALWAYS SEEK THE ADVICE OF YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH PROVIDER WITH ANY QUESTIONS YOU MAY HAVE REGARDING A MEDICAL CONDITION. THE CONTENT, SERVICES AND PRODUCTS SHOULD NOT REPLACE ANY MEDICAL ADVICE YOU HAVE PREVIOUSLY RECEIVED OR MAY RECEIVE IN THE FUTURE.
